{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:14:38Z","timestamp":1790777678235,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","award":["MR\/J008915\/1"],"award-info":[{"award-number":["MR\/J008915\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Community\u05f3s Seventh Framework Programme","award":["HEALTH-F2-2010-241909"],"award-info":[{"award-number":["HEALTH-F2-2010-241909"]}]},{"name":"European Community\u05f3s Seventh Framework Programme","award":["EU-GEI"],"award-info":[{"award-number":["EU-GEI"]}]}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.euroneuro.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,7,20]],"date-time":"2014-07-20T05:16:33Z","timestamp":1405833393000},"page":"725-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?"],"prefix":"10.1016","volume":"25","author":[{"given":"Matthew J.","family":"Kempton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.07.006_bib1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(06)69342-2","article-title":"Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum","volume":"368","author":"Agranoff","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib2","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1176\/appi.ajp.160.8.1421","article-title":"The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes","volume":"160","author":"Arango","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.bp.105.015701","article-title":"Brain volume changes in the first year of illness and 5-year outcome of schizophrenia","volume":"189","author":"Cahn","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archgenpsychiatry.2007.3","article-title":"Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America","volume":"65","author":"Cannon","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroimage.2006.09.011","article-title":"Biological parametric mapping: a statistical toolbox for multimodality brain image analysis","volume":"34","author":"Casanova","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","article-title":"Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-244X-11-18","article-title":"Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder","volume":"11","author":"Costafreda","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jpsychires.2006.05.002","article-title":"Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables","volume":"41","author":"Crespo-Facorro","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib10","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib11","doi-asserted-by":"crossref","unstructured":"Demjaha, A., Murray, R.M., McGuire, P.K., Kapur, S., Howes, O.D., 2012. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am. J. Psychiatry","DOI":"10.1176\/appi.ajp.2012.12010144"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib12","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/npp.2012.113","article-title":"Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia","volume":"37","author":"Egerton","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib13","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1073\/pnas.1115365109","article-title":"Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD","volume":"109","author":"Fair","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2011.1472","article-title":"Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk","volume":"69","author":"Fusar-Poli","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archgenpsychiatry.2010.77","article-title":"Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study","volume":"67","author":"Fusar-Poli","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2003.08.001","article-title":"First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol","volume":"66","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"issue":"Suppl. 407","key":"10.1016\/j.euroneuro.2014.07.006_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1600-0447.2000.00008.x","article-title":"Onset and early course as determinants of the further course of schizophrenia","volume":"102","author":"Hafner","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib18","doi-asserted-by":"crossref","unstructured":"Haijma, S.V., Van Haren, N., Cahn, W., Koolschijn, P.C., Hulshoff Pol, H.E., Kahn, R.S., 2012. Brain volumes in schizophrenia: a meta-analysis in over 18,000 subjects. Schizophr. Bull.","DOI":"10.1093\/schbul\/sbs118"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hbm.21436","article-title":"Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain","volume":"34","author":"Handley","year":"2013","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/mp.2011.20","article-title":"Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study","volume":"16","author":"Howes","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib22","first-page":"3554","article-title":"Selection of spectro-temporal patterns in multichannel MEG with support vector machines for schizophrenia classification","volume":"2008","author":"Ince","year":"2008","journal-title":"Conf. Proc. IEEE Eng. Med. Biol. Soc."},{"issue":"474-485","key":"10.1016\/j.euroneuro.2014.07.006_bib23","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/j.jalz.2011.04.007","article-title":"Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer\u05f3s disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer\u05f3s disease neuroimaging initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u05f3s disease: implications for sequence of pathological events in Alzheimer\u05f3s disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.pnpbp.2005.03.010","article-title":"Apoptotic mechanisms in the pathophysiology of schizophrenia","volume":"29","author":"Jarskog","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neulet.2004.11.004","article-title":"The amygdala in schizophrenia: a trimodal magnetic resonance imaging study","volume":"375","author":"Kalus","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1192\/bjp.bp.108.054320","article-title":"White matter microstructure in schizophrenia: effects of disorder, duration and medication","volume":"194","author":"Kanaan","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpsyc.65.9.1017","article-title":"Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder","volume":"65","author":"Kempton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2010.03.036","article-title":"Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies","volume":"120","author":"Kempton","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.neuroimage.2011.06.080","article-title":"A comprehensive testing protocol for MRI neuroanatomical segmentation techniques: evaluation of a novel lateral ventricle segmentation method","volume":"58","author":"Kempton","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuroimage.2011.11.002","article-title":"Diagnostic neuroimaging across diseases","volume":"61","author":"Kloppel","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib35","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archgenpsychiatry.2009.62","article-title":"Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition","volume":"66","author":"Koutsouleris","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/mp.2009.89","article-title":"Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics","volume":"16","author":"McClay","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","article-title":"Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms","volume":"59","author":"McGorry","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archgenpsychiatry.2009.91","article-title":"Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia","volume":"66","author":"Minzenberg","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pnpbp.2007.08.017","article-title":"Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics","volume":"32","author":"Molina","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopsych.2011.01.032","article-title":"Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies","volume":"70","author":"Olabi","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib41","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S1470-2045(12)70372-8","article-title":"Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study","volume":"13","author":"Olmos","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.neubiorev.2012.01.004","article-title":"Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review","volume":"36","author":"Orru","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib43","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","article-title":"Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis","volume":"162","author":"Perkins","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.schres.2009.08.007","article-title":"Structural magnetic resonance imaging predictors of responsiveness to cognitive behaviour therapy in psychosis","volume":"115","author":"Premkumar","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib45","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.neubiorev.2012.07.012","article-title":"Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication","volume":"36","author":"Radua","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.ajp.2012.12070999","article-title":"DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses","volume":"170","author":"Regier","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib47","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/awp007","article-title":"MRI of hippocampal volume loss in early Alzheimer\u05f3s disease in relation to ApoE genotype and biomarkers","volume":"132","author":"Schuff","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib48","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/hbm.21360","article-title":"Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study","volume":"33","author":"Smieskova","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib49","first-page":"119","article-title":"Three-way (N-way) fusion of brain imaging data based on mCCA+jICA and its application to discriminating schizophrenia","volume":"66C","author":"Sui","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib50","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/cercor\/bhn152","article-title":"Time-lapse mapping of cortical changes in schizophrenia with different treatments","volume":"19","author":"Thompson","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib51","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/schbul\/sbn117","article-title":"Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions","volume":"34","author":"van Os","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib53","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/schbul\/sbq013","article-title":"The impact of substance use on brain structure in people at high risk of developing schizophrenia","volume":"37","author":"Welch","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archpsyc.1992.01820080038006","article-title":"The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability","volume":"49","author":"Williams","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib55","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1210\/jc.2005-0987","article-title":"BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer","volume":"90","author":"Xing","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2014.07.006_bib56","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.neuroimage.2006.11.021","article-title":"Pattern classification using principal components of cortical thickness and its discriminative pattern in schizophrenia","volume":"34","author":"Yoon","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2014.07.006_bib57","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1176\/appi.ajp.2009.09040598","article-title":"D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis","volume":"167","author":"Zhang","year":"2010","journal-title":"Am. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1400203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1400203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T21:10:58Z","timestamp":1565644258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1400203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0924977X1400203X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.07.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}